Johnson & Johnson (NYSE:JNJ) starts late-stage coronavirus vaccine clinical trial
The phase 3 study of JNJ-78436735, which will enroll 60,000 participants, is underway.
Full Article
Johnson & Johnson (NYSE:JNJ) starts late-stage coronavirus vaccine clinical trial
Motley Fool
0 shares
1 views
You might like
Related news coverage
Dow ends 400+ points up in reversal of last week's selloff
Proactive Investors
4:15 pm: Wall Street coasts to big gains The markets made strong gains at the opening bell and never let them go, led by robust..
-
Wall Street looking strong to open the week
Proactive Investors
-
Wall Street rises at the opening bell
Proactive Investors
-
Covid: J&J vaccine shows strong immune response
IndiaTimes
-
US States Granted $200 Mln To Prepare For Covid-19 Vaccine
RTTNews
Advertisement
More coverage
Johnson & Johnson Begins Phase 3 COVID-19 Vaccine Trials
Newsy
Watch VideoA single-shot coronavirus vaccine has entered the final stages of testing.
Johnson & Johnson says it's..
-
Johnson & Johnson Starts Late-Stage Coronavirus Vaccine Clinical Trial
Motley Fool
-
US stocks close sharply lower as tech stock continue retreating
Proactive Investors
-
Wall Street plunges in midday trading, tech stocks disappoint
Proactive Investors
-
Wall Street opens on a mixed footing
Proactive Investors